Perioperative management of the patients with rheumatoid arthritis undergoing fracture

doi:10.3877/cma.j.issn.2096-0263.2019.05.011

Abstract

Abstract:

Rheumatoid arthritis (RA) tends to occur in middle-aged and elderly people. Rheumatoid arthritis is complicated, which is usually associated with many complications. The perioperative management of the patients with rheumatoid arthritis and fracture is difficult and with high risk. In this paper, the perioperative assessment, the perioperative drug administration and the prevention of fracture were reviewed in order to reduce the perioperative risk and ensure medical safety.

Key words: Arthritis, rheumatoid, Fractures, bone, Perioperative period

Yiqiang Zhou, Yunxi He, Kai Chen, Yabing Wu, Mingshan Qiu, Jianxin Zhang. Perioperative management of the patients with rheumatoid arthritis undergoing fracture[J]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2019, 05(05): 301-305.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlngkykfdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2096-0263.2019.05.011

https://zhlngkykfdzzz.cma-cmc.com.cn/EN/Y2019/V05/I05/301

References 59

[1]	Goodman SM,Figgie MA. Arthroplasty in patients with established rheumatoid arthritis (RA): Mitigating risks and optimizing outcomes [J]. Best Pract Res Clin Rheumatol, 2015, 29(4/5): 628-642.
[2]	Zhai L,Song Z,Liu K. The effect of gabapentin on acute postoperative pain in patients undergoing total knee arthroplasty a Meta-Analysis [J]. Medicine, 2016, 95(20): e3673.
[3]	Goodman SM,Springer B,Guyatt G, et al. 2017 American college of rheumatology/American association of hip and knee surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty [J]. J Arthroplasty, 2017, 32(9): 2628-2638.
[4]	Megan, L,Krause, et al. Perioperative management of the patient with rheumatoid arthritis [J]. World J Orthop, 2014, 5(3): 283-291.
[5]	赵良春,肖涟波.类风湿关节炎关节置换围手术期处理[J].国际骨科学杂志, 2014, 35(3): 161-163.
[6]	Kristensen SD,Knuuti J,Saraste A, et al. 2014 ESC/ESA guidelines on non-cardiac surgery:cardiovascular assessment and management [J]. Kardiol Pol, 2014, 72(11): 857-918.
[7]	Zhang J,Chen L,Delzell E, et al. The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis [J]. Ann Rheum Dis, 2014, 73(7): 1301-1308.
[8]	李春,王秀茹,唐熠达,等.全国多中心类风湿关节炎冠心病危险因素的现况调查[J].北京大学学报:医学版, 2012, 44(2): 176-181.
[9]	高展望,甄平.类风湿性关节炎关节置换:围置换期的主要风险管理[J].中国组织工程研究, 2015, 19(53): 8664-8669.
[10]	Koch MC,Pereira IA,Souza Nobre LF, et al. Computed tomography of pulmonary changes in rheumatoid arthritis: carcinoembryonic antigen (CEA) as a marker of airway disease [J]. Rheumatol Int, 2016, 36(4): 531-539.
[11]	Sargin G,Senturk T. Multiple pulmonary rheumatoid nodules [J]. Reumatologia, 2015, 53(5): 276-278.
[12]	Mori S,Koga Y,Sugimoto M. Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis [J]. Respir Med, 2012, 106(11): 1591-1599.
[13]	何善智,丁菱,王敏,等.类风湿关节炎合并肺部类风湿结节的危险因素分析[J].实用医学杂志, 2017, 33(10): 1665-1668.
[14]	Mahmoud I,Tekaya AB,Tekaya R, et al. Pulmonary nodules in a patient with rheumatoid arthritis:Which diagnostic approach is the most appropriate? [J]. Caspian J Intern Med, 2017, 8(3): 220-222.
[15]	Wang JX,Du CG. A retrospective study of clinical characteristics of interstitial lung disease associated with rheumatoid arthritis in Chinese patients [J]. Med Sci Monit, 2015, 21: 708-715.
[16]	宋良月,左大辰,张榕,等.类风湿关节炎合并肺间质疾病患者临床特点[J].中华临床免疫和变态反应杂志, 2015(2): 85-90.
[17]	Kelly CA,Saravanan V,Nisar MA, et al. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics-a large multicentre UK study [J]. Rheumatology, 2014, 53(9): 1676-1682.
[18]	Joaquim AF,Ghizoni E,Tedeschi H, et al. Radiological evaluation of cervical spine involvement in rheumatoid arthritis [J]. Neurosurg Focus, 2015, 38(4): E4.
[19]	刘大猛,周新社.类风湿关节炎患者全膝置换术术前评估[J].中国骨与关节杂志, 2016(2): 153-157.
[20]	20Aires RB,De Carualho JF,Henrique Da Mota LM. Pre-operative anesthetic assessment of patients with rheumatoid arthritis [J]. Rev Bras Reumatol, 2014, 54(3): 213-219.
[21]	史占军,吕厚山,许建中,等.类风湿关节炎的诊断与治疗骨科专家共识[J].中国医学前沿杂志:电子版, 2013, 5(3): 49-52.
[22]	高华利,肖涟波,翟伟韬,等.多模式镇痛与静脉自控镇痛对类风湿关节炎全膝关节置换术围手术期镇痛效果的病例对照研究[J].中国骨伤, 2017, 30(4): 356-359.
[23]	Palabiyik O,Tuna AT,Bayar F, et al. Combined Sciatic-Femoral Nerve Block in Patient with Coexisting Ankylosing Spondylitis and Rheumatoid Arthritis[J]. Firat Med J, 2014, 19(4): 214-216.
[24]	刘凤林,张太平.中国普通外科围手术期血栓预防与管理指南[J].消化肿瘤杂志:电子版, 2016, 54(2): 57-62.
[25]	Granziera S,Cohen AT. VTE primary prevention, including hospitalised medical and orthopaedic surgical patients [J]. Thromb Haemost, 2015, 113(6): 1216-1223.
[26]	Galanis T,Merli GJ. Venous Thromboembolism Prophylaxis in the Patient with Rheumatic Diseases Undergoing Orthopedic Surgery[M]//Perioperative Management of Patients with Rheumatic Disease. Springer New York, 2013:45-56.
[27]	Chung WS,Peng CL,Lin CL, et al. Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study [J]. Ann Rheum Dis, 2014, 73(10): 1774-1780.
[28]	Kim SC,Schneeweiss S,Liu J, et al. Risk of venous thromboembolism in patients with rheumatoid arthritis [J]. Arthritis Care Res (Hoboken), 2013, 65(10): 1600-1607.
[29]	Antonella,Mameli,Francesco, et al. Thromboembolic disease in patients with rheumatoid arthritis undergoing joint arthroplasty: Update on prophylaxes [J]. World J Orthop, 2014, 5(5): 645-652.
[30]	Lee JJ,Pope JE. A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases [J]. Arthritis Res Ther, 2014, 16(5): 435-444.
[31]	中国健康促进基金会血栓与血管专项基金专家委员会,中华医学会呼吸病学分会肺栓塞与肺血管病学组,中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会.医院内静脉血栓栓塞症防治与管理建议[J].中华医学杂志, 2018, 98(18): 1383-1388.
[32]	Caprini JA. Risk assessment as a guide for the prevention of the many faces of venous thromboembolism [J]. Am J Surg, 2010, 199(1 Suppl): S3-10.
[33]	周云杉,穆荣.类风湿关节炎患者接受择期骨科手术围手术期的药物治疗[J/CD].中华关节外科杂志:电子版, 2011, 5(1): 75-79.
[34]	Chechik O,Thein R,Fichman G, et al. The effect of clopidogrel and aspirin on blood loss in hip fracture surgery [J]. Injury, 2011, 42(11): 1277-1282.
[35]	Zhang CG,Wang GD,Liu XY, et al. Safety of continuing aspirin therapy during spinal surgery A systematic review and meta-analysis [J]. Medicine, 2017, 96(46): e8603.
[36]	Meier R,Marthy R,Saely CH, et al. Comparison of preoperative continuation and discontinuation of aspirin in patients undergoing total hip or knee arthroplasty [J]. Eur J Orthop Surg Traumatol, 2016, 26(8): 921-928.
[37]	Santolini E,West R,Giannoudis PV. Risk factors for long bone fracture non-union: a stratification approach based on the level of the existing scientific evidence [J]. Injury, 2015, 46(8): S8-S19.
[38]	徐建国,唐会,姚尚龙,等.肾上腺糖皮质激素围手术期应用专家共识(2017版) [J].临床麻醉学杂志, 2017, 33(7): 712-716.
[39]	Goodman SM. Optimizing perioperative outcomes for older patients with rheumatoid arthritis undergoing arthroplasty: emphasis on medication management [J]. Drugs Aging, 2015, 32(5): 361-369.
[40]	中华医学会骨科学分会.中国骨科大手术静脉血栓栓塞症预防指南[J].中华骨科杂志, 2009, 29(6): 602-604.
[41]	Bang SM,Jang MJ,Kim KH, et al. Prevention of venous thrombo embolism, 2nd edition: Korean Society of Thrombosis and Hemostasis Evidence-based Clinical Practice Guidelines [J]. J Korean Med Sci, 2014, 29(2): 164-171.
[42]	Kearon C,Akl EA,Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report [J]. Chest, 2016, 149(2): 315-352.
[43]	岳辰,周宗科,裴福兴,等.中国髋、膝关节置换术围术期抗纤溶药序贯抗凝血药应用方案的专家共识[J].中华骨与关节外科杂志, 2015, 8(4): 281-285.
[44]	Mohib Y,Rashid RH,Ali M, et al. Does tranexamic acid reduce blood transfusion following surgery for inter-trochanteric fracture? A randomized control trial [J]. J Pak Med Assoc, 2015, 65(11 Suppl 3): S17-S20.
[45]	Gausden EB,Garner MR,Warner SJ, et al. Tranexamic acid in hip fracture patients: a protocol for a randomised, placebo controlled trial on the efficacy of tranexamic acid in reducing blood loss in hip fracture patients [J]. BMJ Open, 2016, 6(6): e010676.
[46]	Farrow LS,Smith TO,Ashcroft GP, et al. A systematic review of tranexamic acid in hip fracture surgery [J]. Br J Clin Pharmacol, 2016, 82(6): 1458-1470.
[47]	Tengberg PT,Foss NB,Palm H, et al. Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip RESULTS OF A RANDOMISED CONTROLLED TRIAL [J]. Bone Joint J, 2016, 98B(6): 747-753.
[48]	Suzuki Y,Wakabayashi T. Management of osteoporosis associated with rheumatoid arthritis and glucocorticoid-induced osteoporosis [J]. Clin Calcium, 2015, 25(12): 1825-1834.
[49]	Ma CC,Xu SQ,Gong X, et al. Prevalence and risk factors associated with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis [J]. Arch Osteoporos, 2017, 12(1): 33.
[50]	Liu JJ,Shan LC,Deng BY, et al. Reason and treatment of failure of proximal femoral nail antirotation internal fixation for femoral intertrochanteric fractures of senile patients [J]. Genet Mol Res, 2014, 13(3): 5949-5956.
[51]	Mueller JU,Baldauf J,Marx S, et al. Cement leakage in pedicle screw augmentation: a prospective analysis of 98 patients and 474 augmented pedicle screws [J]. J Neurosurg Spine, 2016, 25(1): 103-109.
[52]	Hoes JN,Bultink IE,Lems WF. Management of osteoporosis in rheumatoid arthritis patients [J]. Expert Opin Pharmacother, 2015, 16(4): 559-571.
[53]	Feng ZY,Zeng SM,Wang YE, et al. Bisphosphonates for the prevention and treatment of osteoporosis in patients with rheumatic diseases: a systematic review and Meta-Analysis [J]. PLoS One, 2013, 8(12): e80890.
[54]	Panday K,Gona A,Humphrey MB. Medication-induced osteoporosis:screening and treatment strategies [J]. Ther Adv Musculoskelet Dis, 2014, 6(5): 185-202.
[55]	Park JH,Park EK,Koo DW, et al. Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis [J]. BMC Musculoskelet Disord, 2017, 18(1): 152-160.
[56]	Ebina K,Hirao M,Hashimoto J, et al. Assessment of the effects of switching oral bisphosphonates to denosumab or daily teriparatide in patients with rheumatoid arthritis [J]. J Bone Miner Metab, 2018, 36(4): 478-487.
[57]	El-Wakd M,Omar O,Ha SN. Prevalence of silent nontraumatic vertebral fracture in rheumatoid arthritis: relation with disease duration, disease activity, corticosteroid, and hip buckling ratio [J]. Egy Rheumatol Rehabil, 2014, 41(3): 116-121.
[58]	Dirven L,Van Den Broek M,Van Groenendael J, et al. Prevalence of vertebral fractures in a disease activity steered cohort of patients with early active rheumatoid arthritis [J]. BMC Musculoskelet Disord, 2012, 13(1): 125.
[59]	刘文,徐胜前,肖会,等.维生素D缺乏和跌倒在类风湿关节炎合并脊柱骨质疏松性骨折中的临床研究[J].中华风湿病学杂志, 2015, 19(11): 740-744.

Please choose a citation manager

Content to export